Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Immunology/Infectious Diseases | Obstetrics/Gynecology | Dermatology/Plastic Surgery
Disease Category: Genital Herpes

Trial Information

Assess the mucosal immune response to genital herpes simplex virus before and after treatment and determine if cervicovaginal fluid from herpes-infected women affects HIV in vitro

Doctors at Albert Einstein College of Medicine are looking for women ages 18-50 with a vaginal herpes blister or sore to undergo a gynecologic exam for a research study.

The purpose of this research study is to see if treating genital herpes causes a change in the cells in the vagina that protect against infection.

Your part in the study will include 3 visits within 2 weeks.

Subjects will be reimbursed for each visit and will receive anti-herpes therapy free of charge.

Inclusion Criteria:

• Age 18-50 years.
• Suspected genital herpes lesion located on the vulva, vagina, cervix or perineum.
• Agree to anti-HSV treatment.
• Agree to abstain from sexual intercourse and to use vaginal products for the duration of the study (two weeks).

Exclusion criteria:

• Pregnant, breastfeeding, or menopausal.
• HIV
• Vaginitis, UTI or STI including bacterial vaginosis (BV), trichomoniasis, candidiasis, chlamydia, gonorrhea, or syphilis within one month prior to or at screening. Abnormal Pap smear.

Julie, Research Coordinator
Einstein-Montefiore Institute for Clinical & Translational Research
Albert Einstein College of Medicine
1300 Morris Park Avenue
Bronx, NY 10461
Phone: 718-430-3253
EMail: microbicide@aecom.yu.edu

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.